Drug
V0355
V0355: highest development phase Phase 1, developed by Pierre Fabre. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Pierre Fabre
Trials
| Drug | Phase | Indication |
|---|---|---|
| V0355 NCT02518568 | Phase 1 | Iron Deficiency Anemia |
Latest
No recent events.
Follow V0355 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.